Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBasetez oradaEkotizim uchun ochiq API
Lotin
Oʻzbek

Peripheral Neuropathies and Disorders

31 ta ish

  1. Parfumidine

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobDrug-Induced Adverse Reactions20120 iqtibos
    ABI

  2. Thymus vulgaris

    Shakhnoza S. Azimova, Anna I. Glushenkova

    BobPeripheral Neuropathies and Disorders20120 iqtibos
    ABI

  3. Sepaconitine

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobDrug-Induced Adverse Reactions20120 iqtibos
    ABI

  4. Liquiritigenin

    Shakhnoza S. Azimova, Валентина И. Виноградова

    BobPharmacological Effects of Natural Compounds20120 iqtibos
    ABI

  5. Gentianine

    Shakhnoza S. Azimova, Marat S. Yunusov

    BobDrug-Induced Ocular Toxicity20120 iqtibos
    ABI

  6. Escin VIb

    Shakhnoza S. Azimova

    BobMultiple Myeloma Research and Treatments20120 iqtibos
    ABI

  7. The effectiveness of amantadine and dopamine in the treatment of Guillain-Barre syndrome

    Marat Tadjenov, Rustam Sadikov, Y. Musaeva +1

    MaqolaPeripheral Neuropathies and DisordersParkinsonism & Related Disorders20150 iqtibos
    ABI

  8. Dopaminergic medicines are drugs of choice for medicament-resistant facial nerve neuropathy

    A. AZIMOV, Rustam Sadykov, Shuxrat Dadajonov +2

    MaqolaPeripheral Neuropathies and DisordersParkinsonism & Related Disorders20150 iqtibos
    ABI

  9. Dopaminergic medicines are drugs of choice for medicament-resistant facial nerve neuropathy: EMG study

    A. AZIMOV, Rustam Sadykov, Shuxrat Dadajonov +3

    MaqolaFacial Nerve Paralysis Treatment and ResearchParkinsonism & Related Disorders20150 iqtibos
    ABI

  10. Recommendations for cerebrospinal fluid analysis

    D. Hepnar, P. Adam, H. Žáková +13

    Sharh maqolaPeripheral Neuropathies and DisordersFolia Microbiologica20180 iqtibos
    ABI

  11. High efficiency of repeated courses of therapeutic plasmapheresis with transferred guillain-barre syndrome, pathogenically based treatment method

    N. Panjiyeva, S. Dadajonov, R. Sodiqov +5

    MaqolaPeripheral Neuropathies and DisordersJournal of the Neurological Sciences20190 iqtibos
    ABI

  12. Neurological Manifestations of COVID-19

    Madjidova Y.N., MansurovaN.A, TemirovaM.K.

    MaqolaLong-Term Effects of COVID-19International Journal of Medical Science and Clinical Research Studies20210 iqtibos
    ABI

  13. REPLY:

    R. Li, Lin Ma

    BoshqaAutoimmune Neurological Disorders and TreatmentsAmerican Journal of Neuroradiology20220 iqtibos
    ABI

  14. Relation between Guillain-Barré syndrome and Covid-19: Case-Series

    Ibrahim A. Abdelazim, Merey Bakytzhanovna Jumagaliyeva, Dinmukhamed Nurniyazovich Ayaganov +3

    MaqolaPeripheral Neuropathies and DisordersJournal of Medicine and Life20230 iqtibos
    ABI

  15. Neuropathic component of pain, comorbidity and quality of life in rheumathoid arthritis: are there any relationships?

    Н. М. Никитина, Elena V. Egorova, L. R. Bogdalova +2

    MaqolaPain Mechanisms and TreatmentsRussian Journal of Preventive Medicine20230 iqtibos
    ABI

  16. Neurological complications after covid-19 vaccination

    K. Khalimova, Nilufar Rashidova, Javlon Salimjonov

    MaqolaSARS-CoV-2 and COVID-19 ResearchS S Korsakov Journal of Neurology and Psychiatry20230 iqtibos
    ABI

  17. Patterns of Adult Neuromyelitis Optica Spectrum Disorder Patients Compared to Multiple Sclerosis: A Systematic Review and Meta-Analysis

    Mohammed Alqwaifly, Ahmed Althobaiti, Nouf S AlAibani +4

    Sharh maqolaMultiple Sclerosis Research StudiesCureus20230 iqtibos
    ABI

  18. Abstract PO3-28-05: Therapeutic Plasmapheresis as a Symptomatic Treatment for Paclitaxel-Associated Peripheral Polyneuropathy

    Sardor Abdugafforov, Vladimir Vorotnikov, Alexander Soynov +3

    MaqolaCancer Treatment and PharmacologyCancer Research20240 iqtibos
    ABI

  19. Neurological Complications after COVID-19 Vaccination

    K. Khalimova, Nilufar Rashidova, Javlon Salimjonov

    MaqolaPeripheral Neuropathies and DisordersNeuroscience and Behavioral Physiology20240 iqtibos
    ABI

  20. Microscopic Polyangiitis as a Multidisciplinary Problem (Literature Review and Case Report)

    И. Т. Муркамилов, К. А. Айтбаев, Z. Raimzhanov +6

    MaqolaVasculitis and related conditionsBulletin of Science and Practice20240 iqtibos
    ABI

  21. P209 ELECTRONEUROMYOGRAPHY IN THE EARLY STAGES OF DIABETIC POLYNEUROPATHY IN PATIENTS WITH COVID-19

    Rustambek Matmurodov, Surayyo Umirova

    MaqolaLong-Term Effects of COVID-19Neuromodulation Technology at the Neural Interface20250 iqtibos
    ABI

  22. OPTIMIZING THE TREATMENT OF PATIENTS WITH ACUTE SENSORINEURAL PAIN

    Nasretdinova Makhzuna Takhsinovna, Normuradov Nadirjon Alisherovich, NORMIROVA Nargiza Nazarovna

    MaqolaPeripheral Neuropathies and DisordersJournal of Medical Genetics and Clinical Biology20250 iqtibos
    ABI

  23. DIAGNOSTIC CRITERIA OF MULTIPLE SCLEROSIS: CURRENT APPROACHES AND CLINICAL SIGNIFICANCE

    Ilyosbek Yaqubov

    MaqolaMultiple Sclerosis Research StudiesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  24. DIAGNOSTIC CRITERIA OF MULTIPLE SCLEROSIS: CURRENT APPROACHES AND CLINICAL SIGNIFICANCE

    Ilyosbek Yaqubov

    MaqolaMultiple Sclerosis Research StudiesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  25. Efficacy of ocrelizumab in primary progressive multiple sclerosis

    Sevara Khudayarova, Gulnara Rakhmatullayeva

    MaqolaMultiple Sclerosis Research StudiesJournal of the Neurological Sciences20250 iqtibos
    ABI